Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Daiichi Sankyo holds dominant IP positions on the DXd payload and the tetrapeptide-based cleavable linker used in Enhertu (trastuzumab deruxtecan) and Datroway
Sustained elevation of IGF-1 is associated, in observational studies of acromegaly (a disease of GH excess), with increased risk of several cancers including colorectal and breast
An unavoidable practical caveat sits alongside all of this: material sold in the research-chemical channel is not the FDA-approved finished drug, and its identity and purity are not guaranteed
The most common side effects include mild discomfort, redness, or swelling at the injection site
US$ 22.98
US$ 23.49
US$ 28.54
US$ 23.76
US$ 26.98
US$ 21.65
US$ 27.77
US$ 23.57
